Pulsed field ablation selectively spares the oesophagus during pulmonary vein isolation for atrial fibrillation.


Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
08 09 2021
Historique:
received: 05 02 2021
accepted: 26 03 2021
pubmed: 8 5 2021
medline: 21 10 2021
entrez: 7 5 2021
Statut: ppublish

Résumé

Extra-atrial injury can cause complications after catheter ablation for atrial fibrillation (AF). Pulsed field ablation (PFA) has generated preclinical data suggesting that it selectively targets the myocardium. We sought to characterize extra-atrial injuries after pulmonary vein isolation (PVI) between PFA and thermal ablation methods. Cardiac magnetic resonance (CMR) imaging was performed before, acutely (<3 h) and 3 months post-ablation in 41 paroxysmal AF patients undergoing PVI with PFA (N = 18, Farapulse) or thermal methods (N = 23, 16 radiofrequency, 7 cryoballoon). Oesophageal and aortic injuries were assessed by using late gadolinium-enhanced (LGE) imaging. Phrenic nerve injuries were assessed from diaphragmatic motion on intra-procedural fluoroscopy. Baseline CMR showed no abnormality on the oesophagus or aorta. During ablation procedures, no patient showed phrenic palsy. Acutely, thermal methods induced high rates of oesophageal lesions (43%), all observed in patients showing direct contact between the oesophagus and the ablation sites. In contrast, oesophageal lesions were observed in no patient ablated with PFA (0%, P < 0.001 vs. thermal methods), despite similar rates of direct contact between the oesophagus and the ablation sites (P = 0.41). Acute lesions were detected on CMR on the descending aorta in 10/23 (43%) after thermal ablation, and in 6/18 (33%) after PFA (P = 0.52). CMR at 3 months showed a complete resolution of oesophageal and aortic LGE in all patients. No patient showed clinical complications. PFA does not induce any signs of oesophageal injury on CMR after PVI. Due to its tissue selectivity, PFA may improve safety for catheter ablation of AF.

Identifiants

pubmed: 33961027
pii: 6271395
doi: 10.1093/europace/euab090
pmc: PMC8427383
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1391-1399

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

Circulation. 2017 Sep 26;136(13):1247-1255
pubmed: 28947480
Circ Arrhythm Electrophysiol. 2019 Dec;12(12):e007781
pubmed: 31826647
Heart Rhythm. 2013 May;10(5):653-8
pubmed: 23318348
Circulation. 2004 Mar 16;109(10):1226-9
pubmed: 14993124
JACC Clin Electrophysiol. 2018 Dec;4(12):1583-1594
pubmed: 30573123
J Cardiovasc Electrophysiol. 2012 Feb;23(2):147-54
pubmed: 21914018
J Am Coll Cardiol. 2019 Jul 23;74(3):315-326
pubmed: 31085321
Heart Rhythm. 2015 Feb;12(2):268-74
pubmed: 25446159
J Am Coll Cardiol. 2014 Dec 2;64(21):e1-76
pubmed: 24685669
JAMA. 2010 Jan 27;303(4):333-40
pubmed: 20103757
Dig Dis Sci. 2011 Dec;56(12):3453-8
pubmed: 21800159
Heart Rhythm. 2009 Jul;6(7):962-9
pubmed: 19560085
Circ Arrhythm Electrophysiol. 2017 May;10(5):
pubmed: 28487347
J Am Coll Cardiol. 2006 Jun 20;47(12):2498-503
pubmed: 16781380
Heart Rhythm. 2014 Apr;11(4):574-8
pubmed: 24418167
Circulation. 2009 Apr 7;119(13):1758-67
pubmed: 19307477
Heart Rhythm. 2015 Aug;12(8):1838-44
pubmed: 25998897
J Cardiovasc Electrophysiol. 2009 Nov;20(11):1272-8
pubmed: 19572955
Circ Arrhythm Electrophysiol. 2009 Dec;2(6):620-5
pubmed: 20009076
Radiology. 2013 Dec;269(3):738-47
pubmed: 23847254
J Am Coll Cardiol. 2013 Apr 23;61(16):1713-23
pubmed: 23500312
Circ Arrhythm Electrophysiol. 2020 Mar;13(3):e008303
pubmed: 31977250

Auteurs

Hubert Cochet (H)

IHU LIRYC-CHU Bordeaux, Univ. Bordeaux, Inserm U1045, Avenue du Haut Lévêque, 33604 Pessac, France.
Department of Cardiovascular Imaging, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Yosuke Nakatani (Y)

Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Soumaya Sridi-Cheniti (S)

Department of Cardiovascular Imaging, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Ghassen Cheniti (G)

Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

F Daniel Ramirez (FD)

Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Takashi Nakashima (T)

Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Charles Eggert (C)

Farapulse, CA, Farapulse, Los Altos, 3715 Haven Ave Control, Menlo Park, CA 94025, USA.

Christopher Schneider (C)

Farapulse, CA, Farapulse, Los Altos, 3715 Haven Ave Control, Menlo Park, CA 94025, USA.

Raju Viswanathan (R)

Farapulse, CA, Farapulse, Los Altos, 3715 Haven Ave Control, Menlo Park, CA 94025, USA.

Nicolas Derval (N)

IHU LIRYC-CHU Bordeaux, Univ. Bordeaux, Inserm U1045, Avenue du Haut Lévêque, 33604 Pessac, France.
Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Josselin Duchateau (J)

IHU LIRYC-CHU Bordeaux, Univ. Bordeaux, Inserm U1045, Avenue du Haut Lévêque, 33604 Pessac, France.
Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Thomas Pambrun (T)

IHU LIRYC-CHU Bordeaux, Univ. Bordeaux, Inserm U1045, Avenue du Haut Lévêque, 33604 Pessac, France.
Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Remi Chauvel (R)

IHU LIRYC-CHU Bordeaux, Univ. Bordeaux, Inserm U1045, Avenue du Haut Lévêque, 33604 Pessac, France.
Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Vivek Y Reddy (VY)

Department of Cardiac Arhhythmias, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, USA.

Michel Montaudon (M)

IHU LIRYC-CHU Bordeaux, Univ. Bordeaux, Inserm U1045, Avenue du Haut Lévêque, 33604 Pessac, France.
Department of Cardiovascular Imaging, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

François Laurent (F)

IHU LIRYC-CHU Bordeaux, Univ. Bordeaux, Inserm U1045, Avenue du Haut Lévêque, 33604 Pessac, France.
Department of Cardiovascular Imaging, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Frederic Sacher (F)

IHU LIRYC-CHU Bordeaux, Univ. Bordeaux, Inserm U1045, Avenue du Haut Lévêque, 33604 Pessac, France.
Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Mélèze Hocini (M)

IHU LIRYC-CHU Bordeaux, Univ. Bordeaux, Inserm U1045, Avenue du Haut Lévêque, 33604 Pessac, France.
Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Michel Haïssaguerre (M)

IHU LIRYC-CHU Bordeaux, Univ. Bordeaux, Inserm U1045, Avenue du Haut Lévêque, 33604 Pessac, France.
Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Pierre Jais (P)

IHU LIRYC-CHU Bordeaux, Univ. Bordeaux, Inserm U1045, Avenue du Haut Lévêque, 33604 Pessac, France.
Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH